Calliditas Therapeutics AB financial statements, including revenue, expenses, profit, and loss

The total revenue of CALT for the last quarter is 28.42 M USD, and it's 32.85% lower compared to the previous quarter. The net income of Q1 24 is -23.68 M USD.